
Psychedelic Research Studies
Segal Trials is the first to offer psychedelic research in Florida and is pioneering the way for advancements in medicine for the entire country.
We offer a full-service center dedicated to Psychedelic Research. With state-of-the-art equipment in a relaxed and comfortable setting to accommodate our participants. The doctors and staff are experts in the field of psychedelics. Segal Trials has a proven record of 23 years as private research experts changing the treatment paradigm for psychiatric, neurological, and women’s health disorders.
You can be a hero and make medical history by joining one of our psychedelic clinical research trials.
Note: Psychedelic Studies Are Conducted In South Florida.
Participate in our New Clinical Research Study for Generalized Anxiety Disorder Segal Trials is currently conducting a clinical research study to evaluate participants who experience symptoms of General Anxiety Disorder.
Study Details
- Adults 18-74 years old
- Diagnosed with Generalized Anxiety Disorder (GAD)
- Must be in medically stable condition (no high blood pressure)
- Participation in the trial will last approximately 17 week
- No history of illicit use of substances
- No substance or alcohol use disorder within the past 12 months
- Must agree to use highly effective birth control methods during the study
- No diagnosis or a first-degree relative diagnosed with Schizophrenia, Psychotic disorder, or Bipolar
- Additional criteria may apply
Participants who qualify may receive:
- Study Related Exams and Lab Work at No
- Cost Compensation for time and travel up to $900
- Free transportation available
Anxiety Study
"*" indicates required fields
Study Details:
•Men and women 18 years or older
• Diagnosed with Major Depression & past medications have failed
• Currently taking an antidepressant
• Have not been diagnosed with the following: Bipolar, Schizophrenia, PTSD, OCD, Anorexia Nervosa
Depression Study – TRD
"*" indicates required fields
Study Details:
•Men and women 18 years or older
• Diagnosed or experience symptoms of Depression
• Be able to participate in a Video Call
• Good physical health
• Study length: up to 1 year
General Depression
"*" indicates required fields
Study Details:
• 18 years or older
• Diagnosis of moderate to severe alcohol use disorder and otherwise be healthy
Alcohol Use Disorder Study
"*" indicates required fields
Psychedelic Studies Clinical Team

Dr. Rishi Kakar
• Chief Scientific Officer • Medical Director and Principal Investigator • Board Certified Psychiatrist • Diplomate, American Board of Psychiatry and Neurology

Dr. Kristin Hicks
• Psychedelics Therapist

Sarah Coleman
• Screening Specialist / Psychedelics Facilitator

Dr. Scott Fisher
• Lead Psychedelics Therapist

Dr. Eva Nowakowski Sims
• Psychedelics Therapist